| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Section of Preventive Medicine and Epidemiology, Evans Department of Medicine, the School of Medicine, Boston University; the Department of Epidemiology, the School of Public Health, University of North Carolina at Chapel Hill; the Department of Laboratory Medicine and Pathology, Fairview-University Medical Center, Minneapolis; the Division of Epidemiology, University of Minnesota, Minneapolis; the Department of Cardiovascular Genetics, University of Utah, Salt Lake City; and the Division of Biostatistics, Washington University, St Louis.
2 Supported in part by the National Heart, Lung, and Blood Institute cooperative agreement grants U01 HL56563, U01 HL56564, U01 HL56565, U01 HL56566, U01 HL56567, U01 HL56568, and U01 HL56569 and the Institute on Lifestyle and Health, School of Medicine, Boston University. 3 Reprints not available. Address correspondence to L Djoussé, School of Medicine, Boston University, Room B-612, 715 Albany Street, Boston, MA 02118. E-mail: ldjousse{at}bu.edu.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-linolenic acid and cardiovascular disease morbidity and mortality. Objective: We examined the relation between dietary linolenic acid and prevalent coronary artery disease (CAD).
Design: We studied 4584 participants with a mean (±SD) age of 52.1 ± 13.7 y in the National Heart, Lung, and Blood Institute Family Heart Study in a cross-sectional design. Participants' diets were assessed with a semiquantitative food-frequency questionnaire. For each sex, we created age- and energy-adjusted quintiles of linolenic acid, and we used logistic regression to estimate prevalent odds ratios for CAD.
Results: From the lowest to the highest quintile of linolenic acid, the prevalence odds ratios of CAD were 1.0, 0.77, 0.61, 0.58, and 0.60 for the men (P for trend = 0.012) and 1.0, 0.57, 0.52, 0.30, and 0.42 for the women (P for trend = 0.014) after adjustment for age, linoleic acid, and anthropometric, lifestyle, and metabolic factors. Linoleic acid was also inversely related to the prevalence odds ratios of CAD in the multivariate model (0.60 and 0.61 in the second and third tertiles, respectively) after adjustment for linolenic acid. The combined effect of linoleic and linolenic acids was stronger than the individual effects of either fatty acid.
Conclusions: A higher intake of either linolenic or linoleic acid was inversely related to the prevalence odds ratio of CAD. The 2 fatty acids had synergistic effects on the prevalence odds ratio of CAD.
Key Words: Linolenic acid • linoleic acid • n-3 fatty acids • n-6 fatty acids • diet • coronary artery disease • food-frequency questionnaire • National Heart • Lung • Blood Institute Family Heart Study
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-linolenic acid was associated with a lower incidence of ventricular fibrillation and cardiac deaths (7, 8). -Linolenic acid may also reduce the risk of CAD because of its antithrombotic effects (9). Data on the effects of linolenic acid in humans are limited. de Lorgeril et al (4) showed the protective effects of -linolenic acid in a secondary prevention trial of myocardial infarction. In a large prospective study, a higher concentration of -linolenic acid was associated with a reduced risk of fatal ischemic heart disease in women (10). The mechanisms by which linolenic acid affects the risk of CAD in humans are not well known. In addition, it is not known whether this effect is modified by 1) the ratio of linoleic to linolenic acid or 2) the ratio of polyunsaturated to saturated fatty acids (P:S). The conversion of -linolenic acid to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may be affected by the concentration of linoleic acid because linoleic and linolenic acids use the same set of enzymes for desaturation and chain elongation (11). The largest proportion of total linolenic acid is in the form. Linolenic acid is found mostly in flaxseed oil, soy oil, canola oil, and English walnuts, and in smaller concentrations in green leafy vegetables, corn oil, almonds, and hazelnuts (12, 13). The purpose of the present study was to assess the relation between reported intake of linolenic acid and prevalent CAD in 4584 male and female participants of the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study and to examine whether such a relation was influenced by 1) fish consumption, 2) the P:S, and 3) the ratio of linoleic to linolenic acid. In a secondary analysis, we assessed the relation between linoleic acid and CAD, adjusting for linolenic fatty acid and the interaction between the 2 fatty acids.
|
SUBJECTS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Between 1993 and 1995, individuals participating in each of the parent studies were selected at random and invited to provide an updated family-health history that contained information about their parents, children, and siblings. Of the 4679 individuals contacted, 3150 (67%) responded. Their family members were then contacted and self-reported health data were obtained from a total of 22908 individuals (86% of those contacted). Of the families who responded to the health questionnaire, 588 were chosen randomly and 566 were selected on the basis of a higher-than-expected risk of CAD. All members of these families were invited to attend 1 of the 4 study clinics for a clinical evaluation lasting 
4 h. The evaluation included a detailed medical and lifestyle history, which was obtained through an interview. All interviewers were trained centrally and required periodic certification; standardization of interviews was facilitated by a periodic review of sound recorded interviews and by the frequent circulation of the distributions of responses obtained by the different interviewers and the different centers. The study protocol was reviewed and approved by each of the participating institutions.
Dietary assessment
Dietary information was collected with the use of a semiquantitative food-frequency questionnaire that was administered by the staff and developed by Willett (16, 17). The reproducibility and validity of the food-frequency questionnaire was documented elsewhere (18). From the food-frequency questionnaire, intake of specific nutrients was computed by multiplying the frequency of consumption of an item by the nutrient content of specified portions. The compositions of linolenic and linoleic acids and other nutrients were obtained from the HARVARD UNIVERSITY FOOD COMPOSITION DATABASE (Boston, MA), which was created from sources from the US Department of Agriculture (19) and from the food manufacturers' information. This database only provides the content of total linolenic acid. We used the total linolenic acid content in the present analyses because 1) the relation of -linolenic acid to CAD was similar to the association of total linolenic acid to ischemic heart disease in a large prospective study (10), and 2) it was reported that the main sources of dietary 
-linolenic acid are beef fats and other animal fats and that -linolenic concentrations in these fats are very low (20).
Ascertainment of CAD
Prevalent CAD was assessed from the participants' medical history and a 12-lead electrocardiogram. Individuals were considered to have CAD if they reported a history of myocardial infarction, percutaneous transluminal coronary angioplasty, or coronary artery bypass graft that could be validated by a review of their medical records, or if abnormal Q waves (Minnesota codes 1.1–1.2) were detected on a resting 12-lead electrocardiogram (21).
Other variables
The participants were interviewed about cigarette smoking, alcohol intake, and education levels during the clinic visit, and their use of aspirin, multivitamins, vitamins E or C, or hormone replacement therapy was assessed by using a questionnaire and a medication inventory. Information about the type of oil the participants used to deep-fry food, the frequency of their fish intake, and their vegetable consumption was obtained with the food-frequency questionnaire. Physical activity levels for the previous year were estimated by using their self-reports. Anthropometric data were collected while the participants were wearing scrub suits. A balance scale was used to measure body weight and a wall-mounted vertical ruler was used to measure height. Diabetes mellitus was defined as the following: 1) a self-reported history of diabetes, 2) a fasting glucose concentration 
7.8 mmol/L, or 3) the current use of a hypoglycemic agent. LDL-cholesterol concentrations were measured by using the method of Friedewald (22), except for participants with triacylglycerol concentrations >4.5 mmol/L, for whom concentrations were measured by ultracentrifugation (23). Triacylglycerol concentrations were measured by using a peroxidase-coupled method (24). Total cholesterol concentrations were measured by using a commercial cholesterol oxidase method on a Roche Cobas Fara centrifugal analyzer (Boehringer Mannheim Diagnostics, Indianapolis) (25). HDL cholesterol was measured after precipitation of the other lipoprotein fractions by using dextran sulfate (26).
Statistics
Of the 5975 participants who had a clinic examination, 1391 were excluded from the analysis because of missing covariates (n = 275) or probable errors on their food-frequency questionnaires (n = 1116), ie, unreliable answers or 18 questions were left blank (n = 682) or energy intakes were outside a priori ranges [acceptance range: 3347.2–17572.8 kJ for the men (16) and 2510.4–14644 kJ for the women (27) (n = 434)].
Data on the African Americans were limited. There were only 15 prevalent cases of CAD in 178 African Americans (5 cases in 57 men; 10 cases in 121 women). We did not assume that the relation between linolenic acid and CAD in African Americans was similar to that of the whites because the African Americans had a higher mean intake of linolenic acid (0.83 compared with 0.74 g/d), and they were older than the whites (53.7 compared with 52.11 y). In addition, the African Americans had a higher prevalence of diabetes mellitus (14.6% compared with 6.1%) and smoking (25% compared with 14%), a higher proportion of fish consumption (92% compared with 73%), a higher mean systolic blood pressure, higher concentrations of linoleic acid and fish n-3 fatty acids, and higher HDL-cholesterol concentrations than did the whites. Because the limited number of prevalent cases of CAD in the African Americans yielded unstable estimations in stratified analyses, the reported analyses are limited to the whites.
We created sex-specific quintiles of linolenic acid and adjusted them for age and energy intake for the following reasons: 1) eating patterns (number of servings and the amount of energy) differed by sex; 2) energy intake, which is influenced by body size, physical activity levels, and metabolic efficiency (28), differed by sex; and 3) we did not assume linear relations between linolenic acid and prevalent CAD. For each sex, we created quintiles of age. Within each sex-specific age category, we created quintiles of energy. Within each of the 25 age- and energy-specific groups, we generated quintiles of linolenic acid (referred to as age- and energy-adjusted quintiles of linolenic acid).
We used a stepwise regression model to select covariates for adjustment (P for selection < 0.2). Model 1 included CAD as an outcome, and age, age squared, the risk group for CAD (random group compared with high-risk group), field center (4 categories), and 4 indicator variables that compared individuals in the upper 4 quintiles with those in the lowest quintile of linolenic acid intake. Model 2 included all the variables that were in model 1 and the participants' waist-to-hip ratios (3 categories), their education level, prevalent diabetes mellitus, amount of smoking (3 categories), alcohol intake, physical activity level, systolic blood pressure, linoleic acid intake (tertiles), the P:S (tertiles), fish consumption (3 categories), dietary fiber intake, multivitamin use, aspirin use, and LDL-cholesterol, HDL-cholesterol, and triacylglycerol concentrations. Additional adjustments for the use of vitamin E or C and hormone replacement therapy for women did not alter the results. To test for a linear trend across increasing categories of linolenic acid intake, we treated the categories as a continuous variable and used the median linolenic acid intake of each category as the corresponding value. We used a logistic model for categorical variables or a generalized linear model for continuous variables.
To assess the influence of fish intake (rich in n-3 fatty acid) on the studied association, we created 3 categories of fish consumption: 0, 1, and 2 servings/wk and conducted a stratified analysis comparing prevalence odds ratio of CAD in the upper 4 quintiles with the lowest quintile of linolenic acid. We also evaluated the relation between linoleic acid and CAD across tertiles of the ratio of linoleic to linolenic acid, the P:S, and linoleic acid intake. To assess the combined effects of linolenic and linoleic acid intake, we cross-classified tertiles of linoleic acid and tertiles of linolenic acid and created 8 dummy variables by using the group with the lowest tertile of each of the 2 fatty acids as a reference category. We used a bootstrap method in a logistic regression model to correct for the correlation among family members. The bootstrap method, which randomly selects one individual per family for modeling, ran >300 replications. The level was set at 0.05 for statistical significance. All analyses were performed by using PC-SAS (version 6.12; SAS Institute Inc, Cary, NC).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
. In the men (Table 1), a higher intake of dietary linolenic acid was associated with a higher waist-to-hip ratio, a significantly lower education level, a significantly lower physical activity level, a significantly lower P:S and ratio of linoleic to linolenic acid, a significantly higher dietary fiber intake, a significantly higher prevalence of diabetes mellitus, a lower prevalence of aspirin use, and a significantly lower prevalence of current alcohol drinkers. In the women (Table 2), a higher intake of dietary linolenic acid was associated with a significantly higher waist-to-hip ratio, a significantly lower physical activity level, a higher concentration of EPA and DHA, a significantly lower P:S and ratio of linoleic to linolenic acid, a higher prevalence of current smokers, a significantly lower prevalence of current alcohol drinkers, a significantly higher percentage of canola oil use, and a significantly lower percentage of multivitamin use.
|
|
). From the lowest to the highest quintile of linolenic acid, the prevalence odds ratios were 1.0 (reference), 0.77, 0.61, 0.58, and 0.60 in the men and 1.0, 0.57, 0.52, 0.30, and 0.42 in the women after adjustment for age, age squared, field center (4 categories), risk group, energy intake, linoleic acid intake, fish intake, plasma cholesterol, and anthropometric, lifestyle, and metabolic factors. When limited to randomly selected study participants, the data suggested an inverse relation between linolenic acid intake and CAD [ß coefficient ± SE for linolenic acid (g): -0.81097 ± 2.54504].
|
). Fish n-3 fatty acid intake was inversely related to the prevalence odds ratio of CAD (data not shown) in the multivariate analysis. After adjustment for fish n-3 fatty acid intake, fish intake was not associated with CAD in the current study; from the lowest to the highest category of fish intake, the prevalence odds ratios of CAD were 1 (reference), 1.16 (0.64–2.11), and 1.19 (0.61–2.32). When the analysis was repeated to assess whether the relation was influenced by the P:S, the trend indicated an inverse association, mostly in the first 2 tertiles, of the P:S (NS; Table 5). Last, the inverse association between linolenic acid and the prevalence odds ratio of CAD was seen in all tertiles of the ratio of linoleic to linolenic acid although the trend was significant only in the lowest tertile of the ratio of linoleic to linolenic acid (range: 2.3–8.4; Table 6).
|
|
|
). As shown in Table 8, both linoleic acid and linolenic acid intakes were independently and jointly associated with lower prevalence odds ratio of CAD. Participants in the highest tertile of both linoleic acid and linolenic acid intakes had 56% lower prevalence odds ratio than did the participants in the lowest tertile of both fatty acid intakes (95% CI: 0.17, 1.17). Additional analysis, which was limited to the randomly selected participants, suggested an inverse relation between linoleic acid and CAD [ß coefficient ± SE for linoleic acid (g): -0.17088 ± 0.17029].
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
A higher intake of -linolenic acid is recommended for primary and secondary prevention of CAD because of its cardioprotective effects. In an animal model, rats fed an -linolenic acid–enriched diet showed a reduced incidence of ventricular fibrillation and cardiac mortality (7, 8). Epidemiologic studies also suggested that a higher dietary intake of -linolenic acid is associated with cardioprotective effects. In a large secondary prevention trial, de Lorgeril et al (4, 29) showed a significant reduction of cardiovascular mortality in the group assigned to consume a Mediterranean diet enriched with -linolenic acid compared with subjects who consumed their usual diet. In addition, Hu et al (10) reported a 45% reduction in incident fatal myocardial infarction when the highest and lowest quintiles of -linolenic acid intake were compared in the Nurses Health Study. Other epidemiologic studies documented inverse associations between -linolenic acid and ischemic heart disease (2, 30). Our findings are consistent with the results of these previous studies.
Plausible biologic mechanisms by which -linolenic acid may protect against CAD incidence and mortality have been proposed. It has been suggested that a higher intake of -linolenic acid could raise the threshold for arrhythmia. Additional effects of linolenic acid could be mediated through synthesis of long-chain polyunsaturated fatty acids with cardioprotective effects: after ingestion, -linolenic acid is quickly converted to EPA but slowly converted to DHA (11). Both EPA and DHA have been shown to reduce cardiac arrhythmia (31–35). EPA may also protect against thrombosis (36, 37) through the inhibition of platelet cyclooxygenase. In addition, lowering plasma triacyglycerol concentrations (38–40) and increasing endothelial nitric oxide (12) and attenuation of inflammation (41) are other potential mechanisms by which n-3 fatty acids protect against CAD.
A higher intake of linoleic acid may also reduce the incidence of CAD. Riemersma et al (42) reported that linoleic acid concentrations in adipose tissue are inversely related to mortality from CHD. In addition, a diet rich in linoleic acid was shown to lower cholesterol and apolipoprotein B concentrations (43). Although linoleic and linolenic acids use the same enzyme set for their metabolic pathway, linolenic acid has a competitive disadvantage because intakes of linoleic acid are higher than those of linolenic acid (44). It was suggested that the optimal ratio of linoleic to linolenic acid in the diet should be 2.3/1 (13) to maximize the rate of conversion of -linolenic acid to DHA (45). Because linoleic and -linolenic acids compete for desaturase and elongase enzymes, the amount of linoleic acid in the diet can affect the conversion of -linolenic acid to EPA and DHA in vivo. In our study, the highest quintile of linolenic acid intake was associated with a lower prevalence odds ratio of CAD in all tertiles of the ratio of linoleic to linolenic acid. However, the results according to the tertiles of both fatty acids (Table 8
) indicated that a combined intake was associated with a greater reduction in the prevalence odds ratio of CAD in the category with the highest values of both fatty acids.
The present study has some limitations. We used an abbreviated version of a standardized food-frequency questionnaire to estimate the intake of linolenic and linoleic acids. Although we did not have the opportunity to validate the food-frequency questionnaire in this study, Willett et al (17, 18) showed that estimation of nutrients with a similar but more comprehensive semiquantitative food-frequency questionnaire was reasonably valid and reproducible. Because of the cross-sectional design of this study, we can only speculate about the temporal relation of linoleic acid and prevalent CAD. People with CAD are more likely to modify their diet on the basis of medical advice and may also have dietary recall patterns that bias the results. This type of bias would not account completely for the observed association. On the other hand, if subjects with CAD were advised to consume more fish or fish capsules, this would dilute the association between n-3 fatty acid intake and CAD and bias the effect measure toward the null. The fact that we found an inverse relation between n-3 fatty acid intake and CAD suggests that the true prevalence odds ratio would indicate stronger protection without such bias. The strong intercorrelation of the different components of the diet was a methodologic challenge, which made it difficult to assess the independent effects of linolenic acid intake on prevalent CAD. Our inference was not affected by the large number of participants selected because of their higher-than-expected risk of CAD. We know this because an analysis restricted to randomly selected participants indicated a similar trend for an inverse relation of linolenic acid intake to CAD. The large sample size and the multicenter design of the study that incorporated different regions of the US population were strengths of this study.
In summary, the results of this study suggest that a higher intake of either linolenic acid or linoleic acid is associated with a lower prevalence odds ratio of CAD in both men and women. The results also indicate that the combined intake of both fatty acids had synergistic effects.
|
ACKNOWLEDGMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONSUBJECTS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;69:890–7.-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1988;68:159–73.
-Linolenic acid in health and disease. Am J Clin Nutr 1999;69:827–8 (editorial).-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454–9.[Medline]
This article has been cited by other articles:
|
|
 |
|
  L. Djousse, T. Rudich, and J M. Gaziano Nut consumption and risk of heart failure in the Physicians' Health Study I Am. J. Clinical Nutrition, October 1, 2008; 88(4): 930 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Martinelli, D. Girelli, G. Malerba, P. Guarini, T. Illig, E. Trabetti, M. Sandri, S. Friso, F. Pizzolo, L. Schaeffer, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease Am. J. Clinical Nutrition, October 1, 2008; 88(4): 941 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Barcelo-Coblijn, E. J Murphy, R. Othman, M. H Moghadasian, T. Kashour, and J. K Friel Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid Am. J. Clinical Nutrition, September 1, 2008; 88(3): 801 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Campos, A. Baylin, and W. C. Willett {alpha}-Linolenic Acid and Risk of Nonfatal Acute Myocardial Infarction Circulation, July 22, 2008; 118(4): 339 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Austria, M. N. Richard, M. N. Chahine, A. L. Edel, L. J. Malcolmson, C. M.C. Dupasquier, and G. N. Pierce Bioavailability of Alpha-Linolenic Acid in Subjects after Ingestion of Three Different Forms of Flaxseed J. Am. Coll. Nutr., April 1, 2008; 27(2): 214 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhao, T. D Etherton, K. R Martin, P. J Gillies, S. G West, and P. M Kris-Etherton Dietary {alpha}-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects Am. J. Clinical Nutrition, February 1, 2007; 85(2): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Baylin, E. Ruiz-Narvaez, P. Kraft, and H. Campos {alpha}-Linolenic acid, {Delta}6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction Am. J. Clinical Nutrition, February 1, 2007; 85(2): 554 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Harper, M. C. Edwards, and T. A. Jacobson Flaxseed Oil Supplementation Does Not Affect Plasma Lipoprotein Concentration or Particle Size in Human Subjects J. Nutr., November 1, 2006; 136(11): 2844 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Giugliano, A. Ceriello, and K. Esposito The Effects of Diet on Inflammation: Emphasis on the Metabolic Syndrome J. Am. Coll. Cardiol., August 15, 2006; 48(4): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K Gebauer, T. L Psota, W. S Harris, and P. M Kris-Etherton n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1526 - 1535S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Monge-Rojas, H. Campos, and X. Fernandez Rojas Saturated and Cis- and Trans-Unsaturated Fatty Acids Intake in Rural and Urban Costa Rican Adolescents J. Am. Coll. Nutr., August 1, 2005; 24(4): 286 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Djousse, D. K. Arnett, J. J. Carr, J. H. Eckfeldt, P. N. Hopkins, M. A. Province, and R. C. Ellison Dietary Linolenic Acid Is Inversely Associated With Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study Circulation, June 7, 2005; 111(22): 2921 - 2926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Djousse, P. M. Rautaharju, P. N. Hopkins, E. A. Whitsel, D. K. Arnett, J. H. Eckfeldt, M. A. Province, R. C. Ellison, and Investigators of the NHLBI Family Heart Study Dietary Linolenic Acid and Adjusted QT and JT Intervals in the National Heart, Lung, and Blood Institute Family Heart Study J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1716 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oh, F. B. Hu, J. E. Manson, M. J. Stampfer, and W. C. Willett Dietary Fat Intake and Risk of Coronary Heart Disease in Women: 20 Years of Follow-up of the Nurses' Health Study Am. J. Epidemiol., April 1, 2005; 161(7): 672 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Djousse, D. K. Arnett, J. S. Pankow, P. N. Hopkins, M. A. Province, and R. C. Ellison Dietary Linolenic Acid Is Associated With a Lower Prevalence of Hypertension in the NHLBI Family Heart Study Hypertension, March 1, 2005; 45(3): 368 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, A. Ascherio, F. B. Hu, M. J. Stampfer, W. C. Willett, D. S. Siscovick, and E. B. Rimm Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men Circulation, January 18, 2005; 111(2): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghosh, D. Qi, D. An, T. Pulinilkunnil, A. Abrahani, K.-H. Kuo, R. B. Wambolt, M. Allard, S. M. Innis, and B. Rodrigues Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2518 - H2527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhao, T. D. Etherton, K. R. Martin, S. G. West, P. J. Gillies, and P. M. Kris-Etherton Dietary {alpha}-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women J. Nutr., November 1, 2004; 134(11): 2991 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. McCloy, M. A. Ryan, P. B. Pencharz, R. J. Ross, and S. C. Cunnane A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women J. Lipid Res., March 1, 2004; 45(3): 474 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Hauswirth, M. R.L. Scheeder, and J. H. Beer High {omega}-3 Fatty Acid Content in Alpine Cheese: The Basis for an Alpine Paradox Circulation, January 6, 2004; 109(1): 103 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C Davis and P. M Kris-Etherton Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications Am. J. Clinical Nutrition, September 1, 2003; 78(3): 640S - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pischon, S. E. Hankinson, G. S. Hotamisligil, N. Rifai, W. C. Willett, and E. B. Rimm Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women Circulation, July |
